Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lavandula angustifolia contains linalool and linalyl acetate as primary bioactive compounds that modulate GABA neurotransmitter activity. These compounds cross the blood-brain barrier to provide anxiolytic and sedative effects through GABAergic pathways.
Origin & History
Lavandula angustifolia (English lavender) is a fragrant shrub from the Lamiaceae family native to the Mediterranean region, particularly thriving in dry, sunny environments. The plant's flowers and leaves are processed via steam distillation for essential oil or aqueous/ethanol extraction for herbal preparations. Chemically classified as an aromatic herb rich in monoterpenes and phenolic compounds.
Research Narrative (Provisional)
A systematic review of seven RCTs involving 852 patients demonstrated lavender's effectiveness for depression, particularly as an adjunct therapy. Another meta-analysis confirmed significant anxiolytic effects of oral lavender essential oil, while a single-blind RCT in 52 postoperative cardiac patients showed aromatherapy benefits for pain and sleep. Most evidence comes from small-to-moderate trials with calls for larger studies.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Lavandula angustifolia is primarily utilized as an aromatic and medicinal herb rather than a significant dietary source of macronutrients. Key bioactive compounds and their approximate concentrations include: Essential oil (1–3% of dry flower weight) composed principally of linalool (25–45%), linalyl acetate (25–47%), 1,8-cineole (up to 2.5%), camphor (0.5–1.5%), lavandulol (>0.3%), terpinen-4-ol (1–5%), β-caryophyllene (2–5%), and trace amounts of limonene, ocimene, and geraniol. Polyphenolic compounds: rosmarinic acid (approximately 1.5–5.0 mg/g dry weight), caffeic acid, luteolin, luteolin-7-O-glucoside, and apigenin (collectively contributing to antioxidant capacity; total phenolic content approximately 20–60 mg GAE/g dry extract depending on extraction method). Flavonoids: total flavonoid content approximately 5–15 mg quercetin equivalents/g dry weight. Tannins: present at approximately 5–12% in aqueous extracts. Minerals (per 100 g dried herb, approximate): calcium (~215 mg), iron (~12 mg), magnesium (~60 mg), potassium (~250 mg), zinc (~1.5 mg), and manganese (~2 mg). Vitamins: trace amounts of vitamin A (as carotenoid precursors) and vitamin C (~2–4 mg/100 g dried herb), though these are not nutritionally significant at typical usage doses. Macronutrients (per 100 g dried herb, approximate): dietary fiber ~25–30 g, protein ~4–5 g, fat ~1–2 g (largely essential oil fraction), carbohydrates ~50–55 g. Caloric value: approximately 200–250 kcal/100 g dried herb, though typical culinary or therapeutic doses (1–3 g) contribute negligible calories. Bioavailability notes: Linalool and linalyl acetate are rapidly absorbed orally and via inhalation, with peak plasma concentrations achieved within 30–60 minutes of oral administration; rosmarinic acid has moderate oral bioavailability (~1–5%) due to ester hydrolysis in the gut; polyphenol bioavailability is enhanced when consumed with lipids or in encapsulated formulations. Standardized oral preparations (e.g., Silexan®) deliver 80 mg essential oil per capsule with demonstrated systemic availability of key terpenoids.
Reported Mechanism (Provisional)
Linalool and linalyl acetate in lavender essential oil bind to GABA-A receptors, enhancing inhibitory neurotransmission in the central nervous system. These compounds also modulate voltage-gated calcium channels and inhibit glutamate release, contributing to anxiolytic effects. Additionally, lavender constituents influence the hypothalamic-pituitary-adrenal axis, reducing cortisol levels during stress responses.
Clinical Narrative (Provisional)
A systematic review of 7 RCTs (n=852) demonstrated moderate evidence for lavender as an adjunct treatment for depression management. Meta-analyses confirm oral lavender essential oil significantly reduces anxiety symptoms compared to placebo across multiple studies. Clinical trials using 80mg daily of standardized lavender oil (Silexan) show measurable anxiety reduction within 2 weeks. Evidence strength is considered moderate due to variable study methodologies and small sample sizes in some trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.